| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 09/01/2005 | US20050191710 Method for labeling a membrane-localized protein |
| 09/01/2005 | US20050191709 Methods for determining the relative benefits and/or evaluating quantitative changes of products on epithelial tissue |
| 09/01/2005 | US20050191708 Using shape changing microwaveable composites to disperse fluids in closed system |
| 09/01/2005 | US20050191707 Methods for identifying or screening for agents that modulate 17beta-HSD3 |
| 09/01/2005 | US20050191706 Biological scaffold comprising src, major histocompatibility and/or pdz domains for use as diagnostic tool in detection of metabolic disorders |
| 09/01/2005 | US20050191705 Apparatus for detecting binding events between biomolecules which utilizes fluorophore-labeled lipid membranes |
| 09/01/2005 | US20050191704 Assay devices utilizing chemichromic dyes |
| 09/01/2005 | US20050191703 Bioassy for identifying compounds which prevent host proteins interation with viral protein associated with infection, replication, assembly or release; viricides |
| 09/01/2005 | US20050191699 Reactive probe chip, composite substrate and method for fabrication of the same |
| 09/01/2005 | US20050191696 Compounds, methods of screening, and in vitro and in vivo uses involving anti-apoptotic genes and anti-apoptotic gene products |
| 09/01/2005 | US20050191694 Apparatus comprising microarray for parallel screening of analytes found in agricultural, forensic, veterinary and blood samples |
| 09/01/2005 | US20050191693 Bioassay comprising stem cell population for use as models in genomic targeting and drug screening |
| 09/01/2005 | US20050191692 Microarray comprising plurality of antibodies for use in detection of selected drugs in blood sample; toxicological screen |
| 09/01/2005 | US20050191690 Membrane proteins for identifying modulators for prevention and treatment of infection, cell proliferative, neurological, cardiovascular, gastrointestinal, autoimmune/inflammatory and metabolic disorders |
| 09/01/2005 | US20050191687 Method for multiplexed analyte detection |
| 09/01/2005 | US20050191683 Biomolecule sensing method using Field Effect Transistor with controllable Debye length |
| 09/01/2005 | US20050191678 Using polymorphic variation in adrenergic receptor as tool in diagnosing/prognosing genetic disorders |
| 09/01/2005 | US20050191677 Mass spectrometric concentration measurement of proteins |
| 09/01/2005 | US20050191675 Methods of using an array of pooled probes in genetic analysis |
| 09/01/2005 | US20050191673 Nucleotide sequences coding tumor marker genes for use as tool in classification, diagnosis and prognosis of cell proliferative disorders |
| 09/01/2005 | US20050191668 Methods of using peroxisome proliferator-activated receptor alpha target genes |
| 09/01/2005 | US20050191665 Which produce surface-enhanced Raman signals (SERS) when excited by laser; for assays for multiplex detection; metal particles (gold, silver, platinum, copper, or aluminum) with adenine, kinetin, and/or zeatin absorbed within aggregate; emulsion polymerization; colloids; microarrays; kits |
| 09/01/2005 | US20050191664 Method for kidney disease detection |
| 09/01/2005 | US20050191648 Computer-directed assembly of a polynucleotide encoding a target polypeptide |
| 09/01/2005 | US20050191644 Methods for detecting biopolymers; biochips; methods for immobilizing antibodies; and substrates to which antibodies are immobilized |
| 09/01/2005 | US20050191641 Nucleotide sequences coding hydrolase for use as tool in identifying modulators for prevention and treatment of digestion, coagulation, diabetic, cell proliferative, urogenital, eating and nervous system gynecological disorders |
| 09/01/2005 | US20050191632 Cytogenetic abnormalities that are predictive of response to therapy for chronic lymphocytic leukemia |
| 09/01/2005 | US20050191631 Screening compounds for centromere-associated protein E (CENP-E) activity by determining plus end-directed microtubule motor activity, ATPase activity, or microtubule binding activity of a candidate compound, especially on Xenopus CENP-E |
| 09/01/2005 | US20050191629 Polymer extraction methods |
| 09/01/2005 | US20050191627 Enzymes |
| 09/01/2005 | US20050191626 Expression vector comprising gene fusion sequences for use in establishing correlation between genotype and phenotype in cell free expression systems |
| 09/01/2005 | US20050191625 Polynucleotides for use as tags and tag complements, manufacture and use thereof |
| 09/01/2005 | US20050191622 Classifying human red blood cell (RBC) types; blood screening and transfusion |
| 09/01/2005 | US20050191621 CD4-independent HIV envelope proteins as vaccines and therapeutics |
| 09/01/2005 | US20050191620 Particle on membrane assay system |
| 09/01/2005 | US20050191614 High speed drug screening; (near) infrared spectrometry, nuclear magnetic resonance, X-ray diffractometry, neutron diffractometry, light/electron microscopy, harmonic generation, circular/linear dichroism spectrometry, differential scanning calorimetry, Raman spectrometry |
| 09/01/2005 | US20050191612 Using g protein coupled receptors as tool in identifying modulators for treatment and prevention of diabetes; antidiabetic agents |
| 09/01/2005 | US20050191431 Method for the production of a hydrophilic substrate provided with a layer electrode |
| 09/01/2005 | US20050191323 Pharmaceutical formulations comprising paclitaxel, derivatives and pharmaceutically acceptable salts thereof |
| 09/01/2005 | US20050191316 Neisseria genomic sequences and methods of their use |
| 09/01/2005 | US20050191314 vaccine comprosing a mixture of A beta oligomers capable of generating an immune response; prophylaxis and treatment of Alzheimer's disease |
| 09/01/2005 | US20050191306 Cancerous disease modifying antibodies |
| 09/01/2005 | US20050191305 Cancerous disease modifying antibodies |
| 09/01/2005 | US20050191297 Sampling from biopsy of transplanted graft; administering a CD20 antagonist such as rituximab, humanized 2H7, or antibody conjugated to cytotoxic agent |
| 09/01/2005 | US20050191292 of reversing cognitive decline by administering a humanized antibody that binds to A beta; particularly useful for prophylactic and therapeutic treatment of Alzheimer's disease or Down's syndrome. |
| 09/01/2005 | US20050191285 Compounds for eliciting or enhancing immune reactivity to HER-2/neu protein for prevention or treatment of malignancies in which the HER-2/neu oncogene is associated |
| 09/01/2005 | US20050191283 Methods of treating NFAT-related disorders |
| 09/01/2005 | US20050191272 Methods for producing Ex vivo models for inflammatory disease and uses thereof |
| 09/01/2005 | US20050191210 test strip measuring method in which a coloration measurement is conducted while a test strip is being moved, there are detected the optical characteristics R of the ground of a test strip and the optical characteristics T of a test line which has appeared on the test strip, and the test strip ratios |
| 09/01/2005 | US20050190958 Displacement method of knot sizing |
| 09/01/2005 | US20050189710 Sheet material detecting device |
| 09/01/2005 | US20050189239 Sensitive, accurate, low cost flue gas pollution measurement with reference to clean ambient air; electrochemical cell based; nitrogen oxide, nitrogen dioxide, sulfur dioxide, carbon monoxide, oxygen |
| 09/01/2005 | US20050189238 Method and system for sensing gas incorporating an integrated reference element |
| 09/01/2005 | US20050189223 Hydrogen sensor and process for production thereof |
| 09/01/2005 | US20050188859 Production meat analysis system and method |
| 09/01/2005 | US20050188700 Pressure reduction apparatus and method |
| 09/01/2005 | DE202005009960U1 Measurement unit, for capillary electrophoresis, has a capillary array in a micro-fluid chip within a box with conductive walls, a high tension supply and a high frequency transmitter/receiver for non-contact conductivity detection |
| 09/01/2005 | DE10393563T5 Verfahren zur Bestimmung des Elastizitätsmoduls von Papier Method for determining the modulus of elasticity of paper |
| 09/01/2005 | DE10393486T5 Verbesserte Abscheidung eines gelösten Analyten auf hydrophobe Oberfläche durch Desolvatisierung von organischen Lösungsmitteln Improved separation of analyte dissolved hydrophobic surface by desolvation of organic solvents |
| 09/01/2005 | DE10393186T5 Verfahren und Vorrichtung zum korrigieren von Position und Lage eines zu haltenden Objektes Method and apparatus for correcting of position and orientation of an object to be held |
| 09/01/2005 | DE10392663T5 Foto-akustisches Erfassungsverfahren zum Messen der Konzentration von Nicht-Kolenwasserstoff-Komponenten einer methanhaltigen Gasmischung Photoacoustic detection method for measuring the concentration of non-Kolenwasserstoff components of a methane-containing gas mixture |
| 09/01/2005 | DE102004038076A1 Use of annexin A3, or other proteins, as diagnostic markers for cancer, especially of the prostate, also use of modulators of these markers for treating cancer |
| 09/01/2005 | DE102004011341A1 Mikrowellensensor zur Messung einer dielektrischen Eigenschaft eines Produkts Microwave sensor for measuring a dielectric property of a product |
| 09/01/2005 | DE102004008539A1 Vorrichtung und Verfahren zur optischen Auswertung von Teststreifen An apparatus and method for the optical evaluation of test strips |
| 09/01/2005 | DE102004007952B3 Determining depth of recesses formed in supporting substrate involves recording and evaluating time profile of reduction in weight of substrate during evaporation of moistening substance |
| 09/01/2005 | DE102004006470A1 Photometric single-use measurement cuvette is filled with porous or heterogeneous material with inner reflecting surfaces in which material to be examined is dissolved or dispersed in the material pores or absorbed in its surfaces |
| 09/01/2005 | DE102004005878A1 Verfahren zur Überwachung der Herstellung von Biomolekülkristallen A method for monitoring the manufacture of Biomolekülkristallen |
| 09/01/2005 | DE102004005151A1 System for sensing the condition of a medium, especially for estimating the condition and age of oil in a combustion engine has a thermoelectric power supply which derives its energy from the heat contained in the medium or oil |
| 09/01/2005 | CA2567042A1 Enrichment methods for the detection of pathogens and other microbes |
| 09/01/2005 | CA2558770A1 Use of tweak modulators and inhibitors for the treatment of neurological conditions |
| 09/01/2005 | CA2558685A1 Nucleic acid construct containing fulllength genome of human hepatitis c virus, recombinant fulllength virus genome-replicating cells having the nucleic acid construct transferredthereinto and method of producing hepatitis c viral particle |
| 09/01/2005 | CA2557725A1 Highly active glycoproteins-process conditions and an efficient method for their production |
| 09/01/2005 | CA2556982A1 A system for grading of industrial wood |
| 09/01/2005 | CA2556861A1 Protein ligands for nkg2d and ul16 receptors and uses thereof |
| 09/01/2005 | CA2556686A1 Method and device for the characterization of interactions between different species |
| 09/01/2005 | CA2556680A1 Screening methods employing zebrafish and the blood brain barrier |
| 09/01/2005 | CA2556425A1 Methods of modulating il-23 activity; related reagents |
| 09/01/2005 | CA2556418A1 Methods and materials using signaling probes |
| 09/01/2005 | CA2556178A1 Methods and compositions for inferring eye color and hair color |
| 09/01/2005 | CA2556177A1 Genetic predictability for acquiring a disease or condition |
| 09/01/2005 | CA2556141A1 Method and device for detecting feline immunodeficiency virus |
| 09/01/2005 | CA2556098A1 Wound healing composition |
| 09/01/2005 | CA2556027A1 Monoclonal antibodies that specifically block biological activity of a tumor antigen |
| 09/01/2005 | CA2555713A1 Apparatus and methods for monitoring transfusion of blood |
| 09/01/2005 | CA2555542A1 P53 wild-type as biomarker for the treatment with mtor inhibitors in combination with a cytotoxic agent |
| 09/01/2005 | CA2555233A1 Wound healing profile |
| 09/01/2005 | CA2555208A1 Nucleic acid molecules encoding novel murine low-voltage activated calcium channel proteins, designated-alpha 1h, encoded proteins and methods of use thereof |
| 09/01/2005 | CA2554965A1 Antibodies specific for activated confirmation of lfa-1 |
| 09/01/2005 | CA2554482A1 High throughput screening methods for lubricating oil compositions |
| 09/01/2005 | CA2554478A1 High throughput screening methods for fuel compositions |
| 09/01/2005 | CA2554477A1 High throughput screening methods for lubricating oil compositions |
| 09/01/2005 | CA2554384A1 High throughput screening methods for lubricating oil compositions |
| 09/01/2005 | CA2553696A1 Indazole-carboxamide compounds as 5-ht4 receptor agonists |
| 09/01/2005 | CA2553290A1 Pattern recognition of serum proteins for the diagnosis or treatment of physiologic conditions |
| 09/01/2005 | CA2541189A1 Methods to identify evolutionarily significant changes in polynucleotide and polypeptide sequences in prokaryotes |
| 09/01/2005 | CA2539436A1 Using liquid crystals to detect affinity microcontact printed biomolecules |
| 09/01/2005 | CA2498682A1 System for determining insulin dose using carbohydrate to insulin ratio and insulin sensitivity factor |
| 08/31/2005 | EP1569155A1 Method of detecting an error spot in a DNA chip and system using the method |
| 08/31/2005 | EP1568997A2 Surface for detection of interaction between substances and corresponding sensor chip, sensing device and detection method |
| 08/31/2005 | EP1568996A1 Improved binding assays through multiepitope analysis and combined antigen and antibody determination |